Screener
Allogene Therapeutics ALLO Common Stock
Common Stock at other companies
Other financials
Where this comes from
Reported directly by Allogene Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:CommonStockSharesAuthorized.
The source filing: Allogene Therapeutics’s 10-Q, filed May 13, 2026.
- Filed
- May 13, 2026, 4:05 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001628280-26-034585
| Line item | March 31,2026 | December 31,2025 |
|---|---|---|
| Commitments and Contingencies (Notes 6 and 7) | ||
| Stockholders’ equity: | ||
| Preferred stock, $0.001 par value: 10,000,000 shares authorized as of March 31, 2026 and December 31, 2025; no shares were issued and outstanding as of March 31, 2026 and December 31, 2025 | — | — |
| Common stock, $0.001 par value: 400,000,000 shares authorized as of March 31, 2026 and December 31, 2025; 244,816,413 and 229,413,523 shares issued and outstanding as of March 31, 2026 and December 31, 2025, respectively | 245 | 229 |
| Additional paid-in capital | 2,332,129 | 2,302,753 |
| Accumulated deficit | (2,053,316) | (2,010,709) |
| Accumulated other comprehensive income (loss) | (183) | 269 |
| Total stockholders’ equity | 278,875 | 292,542 |
Item 1. Financial Statements - Unaudited
FAQ
- What is Allogene Therapeutics's common stock?
- Allogene Therapeutics (ALLO) reported common stock of 400M in Q1 2026.
- How has Allogene Therapeutics's common stock changed year-over-year?
- Allogene Therapeutics's common stock decreased by 0.0% year-over-year, from 400M to 400M.
- What is the long-term trend for Allogene Therapeutics's common stock?
- Over 5 years (2020 to 2025), Allogene Therapeutics's common stock has grown at a 391.1% compound annual growth rate (CAGR), from 140K to 400M.
- What does common stock mean?
- The par value of all common shares issued and outstanding, typically a nominal amount ($0.01 or $0.001 per share).
Ask your AI about Allogene Therapeutics's common stock.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude